Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer

The interval required for haematological reconstitution following myelosuppressive chemotherapy can be reduced by the infusion of autologous peripheral blood progenitor cells (PBPCs). When carboplatin (C) and paclitaxel (P) are followed by granulocyte colony-stimulating factor (GCSF), multiple cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Barlow, C, Nystrom, M, Oesterling, C, Fennell, D, Ismay, J, Gallagher, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409688/
https://www.ncbi.nlm.nih.gov/pubmed/15054448
http://dx.doi.org/10.1038/sj.bjc.6601697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409688/
https://www.ncbi.nlm.nih.gov/pubmed/15054448
http://dx.doi.org/10.1038/sj.bjc.6601697

Ejemplares similares